vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and FULL HOUSE RESORTS INC (FLL). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $75.4M, roughly 1.0× FULL HOUSE RESORTS INC). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -16.4%, a 6.8% gap on every dollar of revenue. On growth, FULL HOUSE RESORTS INC posted the faster year-over-year revenue change (3.4% vs -16.8%). Over the past eight quarters, FULL HOUSE RESORTS INC's revenue compounded faster (3.9% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Full House Resorts, Inc. is an American casino developer and operator based in Summerlin South, Nevada. The company currently operates five casinos. It is known for the involvement of Gulfstream Aerospace founder Allen Paulson, who was CEO from 1994 to 2000, and former Chrysler chairman Lee Iacocca, who was a major investor in the company from 1995 to 2013. Dan Lee has been CEO since late 2014.

BIOX vs FLL — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.0× larger
BIOX
$77.6M
$75.4M
FLL
Growing faster (revenue YoY)
FLL
FLL
+20.2% gap
FLL
3.4%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
6.8% more per $
BIOX
-9.6%
-16.4%
FLL
Faster 2-yr revenue CAGR
FLL
FLL
Annualised
FLL
3.9%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
FLL
FLL
Revenue
$77.6M
$75.4M
Net Profit
$-7.4M
$-12.4M
Gross Margin
46.8%
93.1%
Operating Margin
9.3%
-1.3%
Net Margin
-9.6%
-16.4%
Revenue YoY
-16.8%
3.4%
Net Profit YoY
-20.2%
-0.6%
EPS (diluted)
$-0.12
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
FLL
FLL
Q4 25
$75.4M
Q3 25
$77.6M
$78.0M
Q2 25
$73.9M
Q1 25
$60.6M
$75.1M
Q4 24
$98.8M
$73.0M
Q3 24
$93.3M
$75.7M
Q2 24
$73.5M
Q1 24
$84.0M
$69.9M
Net Profit
BIOX
BIOX
FLL
FLL
Q4 25
$-12.4M
Q3 25
$-7.4M
$-7.7M
Q2 25
$-10.4M
Q1 25
$-1.6M
$-9.8M
Q4 24
$605.2K
$-12.3M
Q3 24
$-6.2M
$-8.5M
Q2 24
$-8.6M
Q1 24
$9.8M
$-11.3M
Gross Margin
BIOX
BIOX
FLL
FLL
Q4 25
93.1%
Q3 25
46.8%
93.2%
Q2 25
93.5%
Q1 25
39.4%
93.4%
Q4 24
42.0%
92.1%
Q3 24
40.2%
92.2%
Q2 24
92.4%
Q1 24
50.8%
92.3%
Operating Margin
BIOX
BIOX
FLL
FLL
Q4 25
-1.3%
Q3 25
9.3%
4.4%
Q2 25
-0.1%
Q1 25
1.5%
1.0%
Q4 24
14.5%
-1.9%
Q3 24
2.5%
3.2%
Q2 24
3.2%
Q1 24
15.7%
-0.9%
Net Margin
BIOX
BIOX
FLL
FLL
Q4 25
-16.4%
Q3 25
-9.6%
-9.8%
Q2 25
-14.0%
Q1 25
-2.6%
-13.0%
Q4 24
0.6%
-16.9%
Q3 24
-6.6%
-11.2%
Q2 24
-11.7%
Q1 24
11.6%
-16.1%
EPS (diluted)
BIOX
BIOX
FLL
FLL
Q4 25
$-0.35
Q3 25
$-0.12
$-0.21
Q2 25
$-0.29
Q1 25
$-0.02
$-0.27
Q4 24
$0.00
$-0.34
Q3 24
$-0.10
$-0.24
Q2 24
$-0.25
Q1 24
$0.14
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
FLL
FLL
Cash + ST InvestmentsLiquidity on hand
$15.5M
$40.7M
Total DebtLower is stronger
$473.6M
Stockholders' EquityBook value
$288.3M
$2.5M
Total Assets
$734.9M
$649.8M
Debt / EquityLower = less leverage
186.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
FLL
FLL
Q4 25
$40.7M
Q3 25
$15.5M
$30.9M
Q2 25
$32.1M
Q1 25
$38.5M
$30.7M
Q4 24
$29.2M
$40.2M
Q3 24
$32.3M
$25.9M
Q2 24
$31.1M
Q1 24
$16.4M
$25.7M
Total Debt
BIOX
BIOX
FLL
FLL
Q4 25
$473.6M
Q3 25
$473.1M
Q2 25
$467.5M
Q1 25
$471.7M
Q4 24
$468.1M
Q3 24
$467.4M
Q2 24
$466.6M
Q1 24
$465.9M
Stockholders' Equity
BIOX
BIOX
FLL
FLL
Q4 25
$2.5M
Q3 25
$288.3M
$14.2M
Q2 25
$21.2M
Q1 25
$345.0M
$31.0M
Q4 24
$346.3M
$40.5M
Q3 24
$346.0M
$51.8M
Q2 24
$59.5M
Q1 24
$348.5M
$67.3M
Total Assets
BIOX
BIOX
FLL
FLL
Q4 25
$649.8M
Q3 25
$734.9M
$644.4M
Q2 25
$651.5M
Q1 25
$798.2M
$657.2M
Q4 24
$835.2M
$673.3M
Q3 24
$827.3M
$668.7M
Q2 24
$673.9M
Q1 24
$836.1M
$670.4M
Debt / Equity
BIOX
BIOX
FLL
FLL
Q4 25
186.62×
Q3 25
33.30×
Q2 25
22.04×
Q1 25
15.22×
Q4 24
11.56×
Q3 24
9.02×
Q2 24
7.85×
Q1 24
6.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
FLL
FLL
Operating Cash FlowLast quarter
$14.4M
$12.0M
Free Cash FlowOCF − Capex
$10.7M
FCF MarginFCF / Revenue
14.1%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
FLL
FLL
Q4 25
$12.0M
Q3 25
$14.4M
$-472.0K
Q2 25
$7.9M
Q1 25
$23.3M
$-9.5M
Q4 24
$-5.4M
$14.8M
Q3 24
$5.2M
$-6.7M
Q2 24
$10.1M
Q1 24
$-17.4M
$-4.4M
Free Cash Flow
BIOX
BIOX
FLL
FLL
Q4 25
$10.7M
Q3 25
$-5.5M
Q2 25
$4.5M
Q1 25
$-12.3M
Q4 24
$6.9M
Q3 24
$-17.4M
Q2 24
$-1.2M
Q1 24
$-27.0M
FCF Margin
BIOX
BIOX
FLL
FLL
Q4 25
14.1%
Q3 25
-7.1%
Q2 25
6.1%
Q1 25
-16.4%
Q4 24
9.4%
Q3 24
-23.0%
Q2 24
-1.6%
Q1 24
-38.7%
Capex Intensity
BIOX
BIOX
FLL
FLL
Q4 25
1.8%
Q3 25
6.5%
Q2 25
4.5%
Q1 25
3.8%
Q4 24
10.9%
Q3 24
14.1%
Q2 24
15.4%
Q1 24
32.4%
Cash Conversion
BIOX
BIOX
FLL
FLL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
Q1 24
-1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

FLL
FLL

Midwest And South$58.2M77%
Food And Beverage$9.7M13%
Other Operations$3.6M5%
Other$2.3M3%
Contracted Sports Wagering$1.7M2%

Related Comparisons